Form D · Biotechnology

Nok Therapeutics, Inc.

Cranberry Twp., PA · CIK 0002038166

Offering snapshot reported May 1, 2026 · SEC filing

Reported sold
$751K
Indefinite offering
Investors reported
5
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 24, 2024
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$375K$751KOct 24, 2025: $250,500.00Oct 24, 2025Apr 22, 2026: $500,500.00May 1, 2026: $750,500.00May 1, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$250,500 → $750,500
  • Reported investors3 → 5

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 1, 2026Amendment$750,500$500,000vs Oct 24, 20255SEC filing
May 1, 2026Amendment$3,200$1,800vs Mar 26, 202614SEC filing
Apr 22, 2026Amendment$1,400$0vs Mar 26, 20269SEC filing
Apr 22, 2026Amendment$649,000$82,500vs Oct 24, 202517SEC filing
Apr 22, 2026Amendment$500,500$250,000vs Oct 24, 20254SEC filing
Mar 26, 2026Initial$1,400No comparison9SEC filing
Oct 24, 2025Initial$250,500No comparison3SEC filing
Oct 24, 2025Initial$566,500No comparison17SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-562020

Source: Form D, filed May 1, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Bruce Cassidy Director
Brian Cogley Director, Executive
Robert Lewis Director, Executive, Promoter
Martin Lewis Director
Michael Lewis Promoter
David Mehalick Promoter

Issuer details

Industry: Biotechnology (See others in industry)

Address:
2009 Mackenzie Way Suite 100
Cranberry Twp., PA, 16066